A Single-Center, Open-Label, One-Sequence, Crossover Study to Investigate the Effects of Multiple Doses of Fluvoxamine on the Pharmacokinetics of a Single Dose RO4917523 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2016
At a glance
- Drugs Basimglurant (Primary) ; Fluvoxamine
- Indications Fragile X syndrome; Major depressive disorder; Obsessive-compulsive disorders; Social phobia
- Focus Pharmacokinetics
- Sponsors Roche
- 10 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 20 Aug 2012 New trial record